DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Eichelberg C, Heuer R, Chun FK, Hinrichs K, Zacharias M, Huland H, Heinzer H.
Sequential use of the tyrosine kinase inhibitors sorafenib
and sunitinib in metastatic renal cell carcinoma: a retrospective outcome
analysis.
Eur Urol 2008; 54: 1373-1378
We do not assume any responsibility for the contents of the web pages of other providers.